JP2003533188A5 - - Google Patents

Download PDF

Info

Publication number
JP2003533188A5
JP2003533188A5 JP2001580979A JP2001580979A JP2003533188A5 JP 2003533188 A5 JP2003533188 A5 JP 2003533188A5 JP 2001580979 A JP2001580979 A JP 2001580979A JP 2001580979 A JP2001580979 A JP 2001580979A JP 2003533188 A5 JP2003533188 A5 JP 2003533188A5
Authority
JP
Japan
Prior art keywords
amino acid
polypeptide
acid sequence
isolated
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001580979A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003533188A (ja
Filing date
Publication date
Priority claimed from US09/704,707 external-priority patent/US7691604B1/en
Application filed filed Critical
Priority claimed from PCT/US2001/014519 external-priority patent/WO2001083555A2/en
Publication of JP2003533188A publication Critical patent/JP2003533188A/ja
Publication of JP2003533188A5 publication Critical patent/JP2003533188A5/ja
Pending legal-status Critical Current

Links

JP2001580979A 2000-05-04 2001-05-04 疼痛シグナル伝達分子 Pending JP2003533188A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US20202700P 2000-05-04 2000-05-04
US60/202,027 2000-05-04
US22234400P 2000-08-01 2000-08-01
US60/222,344 2000-08-01
US09/704,707 US7691604B1 (en) 2000-05-04 2000-11-03 MRG polypeptides and nucleic acids encoding the same
US09/704,707 2000-11-03
US28549301P 2001-04-19 2001-04-19
US60/285,493 2001-04-19
PCT/US2001/014519 WO2001083555A2 (en) 2000-05-04 2001-05-04 Pain signaling molecules

Publications (2)

Publication Number Publication Date
JP2003533188A JP2003533188A (ja) 2003-11-11
JP2003533188A5 true JP2003533188A5 (enExample) 2006-01-05

Family

ID=27498450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001580979A Pending JP2003533188A (ja) 2000-05-04 2001-05-04 疼痛シグナル伝達分子

Country Status (7)

Country Link
EP (1) EP1280904B1 (enExample)
JP (1) JP2003533188A (enExample)
AT (1) ATE312919T1 (enExample)
AU (1) AU2001259508A1 (enExample)
CA (1) CA2407219A1 (enExample)
DE (1) DE60115878T2 (enExample)
WO (1) WO2001083555A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064822A1 (en) * 2000-03-13 2002-05-30 Ming-Hui Wei Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
AU2001296150A1 (en) 2000-10-17 2002-04-29 Astrazeneca Ab Assays
US20040076951A1 (en) * 2000-10-25 2004-04-22 Ming-Hui Wei Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
AU2002231780A1 (en) * 2001-02-08 2002-08-19 Bayer Aktiengesellschaft Human dorsal root receptor-like g protein-coupled receptor
DE10225443A1 (de) 2002-06-08 2003-12-18 Aventis Pharma Gmbh Verfahren zur Identifizierung von Agonisten oder Antagonisten für den G-Protein gekoppelten Rezeptor mas like 1
AU2003275712A1 (en) * 2002-10-29 2004-05-25 Takeda Pharmaceutical Company Limited H17t213-transgenic animal, novel h17t213 protein and dna thereof
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
DE10310758A1 (de) * 2003-03-11 2004-09-23 Grünenthal GmbH Identifizierung von schmerzrelevanten Genen der SNSR (Sensory Neuron Specific Receptor)-Familie
WO2005003763A2 (en) * 2003-06-18 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3)
US7268109B2 (en) 2003-10-02 2007-09-11 Elan Pharmaceuticals, Inc. Method for reducing pain
WO2005114208A1 (en) * 2004-05-13 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mas-related gene mrgd (mrgd)
WO2006005470A2 (en) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor e (mrge)
WO2006066599A2 (en) * 2004-12-22 2006-06-29 Rheoscience A/S Mas related g protein coupled receptors as drug targets
CN112266931B (zh) * 2020-10-15 2022-04-29 海湃泰克(北京)生物医药科技有限公司 特异性表达hMRGPRX4的转基因大鼠的构建方法及其应用
CN118956756B (zh) * 2024-09-29 2025-07-25 中国人民解放军空军军医大学 一种痛感受器皮肤类器官芯片及其培养基、构建方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704836D0 (sv) * 1997-12-22 1997-12-22 Astra Pharma Inc Novel receptor
JP2000023676A (ja) * 1998-07-14 2000-01-25 Asahi Chem Ind Co Ltd 7回膜貫通型受容体蛋白質erg5

Similar Documents

Publication Publication Date Title
JP2003533188A5 (enExample)
WO2004043382A3 (en) Enhanced variants of erythropoietin and methods of use
ATE269902T1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
TW200602071A (en) Methods for preventing and treating alzheimer's disease (ad)
JP2003505343A5 (enExample)
WO2002042459A3 (en) Position dependent recognition of gnn nucleotide triplets by zinc fingers
NZ516477A (en) Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
WO2002044320A3 (en) Human elongase genes and uses thereof
WO2001066597A3 (en) Inflammation-related gene
JP2005506275A5 (enExample)
MXPA05008704A (es) Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
WO2008051496A3 (en) Use of il-1 antagonists to treat gout and pseudogout
WO2003005880A3 (en) Replikin peptides and uses thereof
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2002059346A3 (en) Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
WO2007021886A3 (en) Truncated memapsin 2 for use for treating alzheimer's disease
DK1969003T3 (da) Anvendelser af et neurotrofisk faktor-protein
KR970701724A (ko) 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin)
JP2009500045A5 (enExample)
WO2005086825A3 (en) Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
WO2001010893A3 (en) Il-16 antagonists
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
WO2002013845A3 (en) Inflammation related g-protein coupled receptor
DK0811068T3 (da) Humane DNase I varianter
ATE282704T1 (de) Isolierte und gereinigte humane lösliche guanylylcyclase alpha1/beta1 (hsgc alpha1/beta1)